台股 » 藥華藥 » 個股財報 » 負債和股東權益

藥華藥

(6446)
可現股當沖
  • 股價
    585
  • 漲跌
    ▼11
  • 漲幅
    -1.85%
  • 成交量
    1,198
  • 產業
    上市 生技醫療類股 ▼1.61%
  • 本地時間:14:30(已收盤)

    311人加入追蹤

    立即追蹤

藥華藥 (6446) 財務報表-負債和股東權益
股東權益

流動負債:一年內到期的負債。其典型的組成有:短期銀行借款,例如銀行透支,應付商業本票,應付票據,應付帳款,應付費用,長期借款於一年到期的部分,付給債權人的款項。

長期負債:到期日在一年以上的各種融資借款,如期間在一年以上的銀行借款,應付公司債等。一般而言,除了還款期長之外、長期負債還有金額較大、利息較高等特性。

總負債:企業承擔並需要償還的全部債務。包括流動負債和長期負債、遞延稅項等,即為企業資產負債表的負債合計項。

總資產:總負債+淨值的總和,指企業擁有或控制的全部資產。包括流動資產、長期投資、固定資產、無形及遞延資產、其他長期資產、遞延稅項等,即為企業資產負債表的資產總計項。

藥華藥 (6446) 負債與季收盤價比較圖

藥華藥 (6446) 歷年負債和股東權益

年度/季別流動負債長期負債其餘負債總負債淨值總資產
2024Q32,006,7371,053,57803,060,31526,084,24029,144,555
2024Q21,863,0061,013,46702,876,47325,318,84528,195,318
2024Q11,832,633988,83002,821,46324,413,34027,234,803
2023Q42,152,0931,169,07403,321,16723,948,15027,269,317
2023Q32,177,936854,36003,032,29623,848,16526,880,461
2023Q21,742,894629,77202,372,66625,238,00127,610,667
2023Q13,874,963547,74604,422,70912,148,88716,571,596
2022Q42,550,348641,06503,191,41312,141,21515,332,628
2022Q31,304,416710,59502,015,0115,410,4007,425,411
2022Q21,045,588683,40301,728,9915,614,6227,343,613
2022Q1968,655554,54901,523,2044,018,8205,542,024
2021Q41,411,962535,84001,947,8024,250,3816,198,183
2021Q31,031,955517,99101,549,9461,928,4393,478,385
2021Q2938,803498,96401,437,7672,616,0624,053,829
2021Q11,072,363516,06901,588,4323,152,5544,740,986
2020Q41,086,699524,77701,611,4763,919,7105,531,186
2020Q3897,812496,53801,394,3504,998,1856,392,535
2020Q2727,730357,92701,085,6573,353,4994,439,156
2020Q1317,520353,4940671,0141,988,7332,659,747
2019Q4336,678367,6560704,3342,255,0762,959,410
2019Q3367,554367,9830735,5371,829,9662,565,503
2019Q2277,573381,5240659,0972,069,2942,728,391
2019Q1248,476379,9920628,4682,230,4582,858,926
藥華藥P1101新藥 通過日本PMDA三期臨床試驗申請核准Anue鉅亨-2024/10/25
藥華藥 相關文章